Actively Recruiting
Open-label Study Evaluating How UBT251 Affects Blood Levels of Midazolam, Caffeine, and Warfarin in Adults With Overweight or Obesity
Led by Novo Nordisk A/S · Updated on 2026-08-18
44
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research study focuses on adults with overweight or obesity to evaluate the safety and effects of a drug called UBT251 when taken together with other medicines like midazolam, caffeine, and warfarin. The goal is to understand how UBT251 influences the blood levels of these medicines by looking at how the body processes them. This study is a phase 1, open-label trial designed to assess treatment effects in participants with excess body weight. Participants will receive UBT251 through injections under the skin, with doses gradually increased during the study. At specific visits, they will also take an oral cocktail containing warfarin, caffeine, and midazolam to see how UBT251 affects the metabolism of these drugs. The study uses a single-sequence crossover design where each participant receives both treatments in a set order to compare results. Throughout the study, participants will undergo blood tests to measure the concentration of warfarin, caffeine, and midazolam over time, focusing on key measures like area under the curve and maximum concentration after a single dose. These evaluations will occur from the first dose up to about 156 days. Safety will be monitored through medical history, physical exams, vital signs, ECGs, and lab tests. The total participation time will depend on the study schedule, with a primary completion date set for April 2027.
CONDITIONS
Brief Title
A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
Research Team
N
Novo Nordisk
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here